Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.

Panozzo CA, Becker-Dreps S, Pate V, Weber DJ, Jonsson Funk M, Stürmer T, Brookhart MA.

Am J Epidemiol. 2014 Apr 1;179(7):895-909. doi: 10.1093/aje/kwu001. Epub 2014 Feb 26.

2.

Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, Patel MM, Baggs JM, Parashar UD.

Pediatrics. 2009 Mar;123(3):744-9. doi: 10.1542/peds.2008-1200.

PMID:
19254997
3.

Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD; New Vaccine Surveillance Network (NVSN)..

Clin Infect Dis. 2011 Aug 1;53(3):245-53. doi: 10.1093/cid/cir307. Epub 2011 Jun 23.

PMID:
21705316
4.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Erratum in: Pediatr Infect Dis J. 2011 Oct; 30(10):916.

PMID:
21183837
5.

Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.

Pediatr Infect Dis J. 2013 Mar;32(3):278-83. doi: 10.1097/INF.0b013e318275328f.

PMID:
23014356
6.

Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.

Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S, Asoyan A, Gevorgyan Z, Kocharyan K, Avagyan T, Lopman B, Vanyan A, Khactatryan S, Parashar UD, Cortese MM.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S147-54. doi: 10.1093/cid/ciw045.

PMID:
27059349
7.
8.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
9.

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Review.

PMID:
20518582
10.

The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.

Muhsen K, Chodick G, Goren S, Shalev V, Cohen D.

Vaccine. 2010 Dec 10;29(1):91-4. doi: 10.1016/j.vaccine.2010.10.010. Epub 2010 Oct 20.

PMID:
20969927
11.

Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

BioDrugs. 2010 Dec 1;24(6):411-4. doi: 10.2165/11205070-000000000-00000.

PMID:
21043548
12.

Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.

Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, McNeal M, Klein EJ, Sahni LC, Johnston SH, Harrison CJ, Baker CJ, Bernstein DI, Moffatt ME, Tate JE, Mijatovic-Rustempasic S, Esona MD, Wikswo ME, Curns AT, Sulemana I, Bowen MD, Gentsch JR, Parashar UD.

Clin Infect Dis. 2015 Dec 15;61(12):1792-9. doi: 10.1093/cid/civ872. Epub 2015 Oct 8.

PMID:
26449565
13.

Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.

Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S49-56. doi: 10.1086/605036.

PMID:
19817614
14.

Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.

Castilla J, Beristain X, Martínez-Artola V, Navascués A, García Cenoz M, Alvarez N, Polo I, Mazón A, Gil-Setas A, Barricarte A.

Vaccine. 2012 Jan 11;30(3):539-43. doi: 10.1016/j.vaccine.2011.11.071. Epub 2011 Nov 26.

PMID:
22122860
15.

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60. doi: 10.1097/INF.0b013e3181fefdc0. Review.

PMID:
21183842
16.

Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.

Field EJ, Vally H, Grimwood K, Lambert SB.

Pediatrics. 2010 Sep;126(3):e506-12. doi: 10.1542/peds.2010-0443. Epub 2010 Aug 23.

PMID:
20732946
17.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
18.

Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.

Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, Cohen D.

Hum Vaccin. 2010 Jun;6(6):450-4. Epub 2010 Jun 1.

PMID:
20448471
19.

A reverse evidence of rotavirus vaccines impact.

Martinón-Torres F, Aramburo A, Martinón-Torres N, Cebey M, Seoane-Pillado MT, Redondo-Collazo L, Martinón-Sánchez JM.

Hum Vaccin Immunother. 2013 Jun;9(6):1289-91. doi: 10.4161/hv.24182. Epub 2013 Mar 6.

20.

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.

Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, Patel M, Parashar U, Lopman B.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S200-7. doi: 10.1093/cid/ciw014.

PMID:
27059357

Supplemental Content

Support Center